Tag: sirolimus-eluting balloon
12-month PRISTINE registry data show efficacy of sirolimus-eluting balloon in the...
Tze Tec Chong (Singapore General Hospital, Singapore) presented results from the PRISTINE registry at this year’s Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2023...
First patient enrolled globally in SELUTION SLR study for AV fistulae
MedAlliance has announced enrolment of the first patient in the SAVE (Use of the Selution sirolimus-eluting balloon for dysfunctional AV access treatment indications) study...
Orchestra BioMed announce FDA breakthrough device designation for Virtue sirolimus-eluting balloon
Orchestra BioMed, in partnership with Terumo Corporation, today announced that the company has secured breakthrough device designation by the US Food and Drug Administration...
Virtue sirolimus-eluting balloon set for commercial release as Terumo and Orchestra...
Orchestra BioMed and Terumo have formed a global strategic partnership for the development and commercialisation of Virtue sirolimus-eluting balloon (SEB) in the percutaneous coronary...
